 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
News Briefs Abbott Sets More Africa AIDS Drug Price CutsApril 30, 2002 Abbott Laboratories CEO Miles White on Friday said the drugmaker would further cut the prices of its AIDS drugs for African nations, responding to some shareholders who urged the company to do more for countries ravaged by the deadly disease. Although Abbott shareholders defeated by a resounding 96 percent margin a resolution that would have put the company's AIDS treatments within the $300 to $400 annual budget of an African family, White said the drugmaker will "revisit" easing costs. Abbott already is selling two treatments to African countries at cost. White declined to say by how much drug prices would be cut for Africa or when the cuts would be implemented. Chicago Tribune 04.27.02; Bruce Japsen  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
